Pressure Overload by Transverse Aortic Constriction Induces Maladaptive Hypertrophy in a Titin-Truncated Mouse Model

Qifeng Zhou, Scott Kesteven, Jianxin Wu, Parwez Aidery, Meinrad Gawaz, Michael Gramlich, Michael P Feneley, Richard P Harvey, Qifeng Zhou, Scott Kesteven, Jianxin Wu, Parwez Aidery, Meinrad Gawaz, Michael Gramlich, Michael P Feneley, Richard P Harvey

Abstract

Mutations in the giant sarcomeric protein titin (TTN) are a major cause for inherited forms of dilated cardiomyopathy (DCM). We have previously developed a mouse model that imitates a TTN truncation mutation we found in a large pedigree with DCM. While heterozygous Ttn knock-in mice do not display signs of heart failure under sedentary conditions, they recapitulate the human phenotype when exposed to the pharmacological stressor angiotensin II or isoproterenol. In this study we investigated the effects of pressure overload by transverse aortic constriction (TAC) in heterozygous (Het) Ttn knock-in mice. Two weeks after TAC, Het mice developed marked impairment of left ventricular ejection fraction (p < 0.05), while wild-type (WT) TAC mice did not. Het mice also trended toward increased ventricular end diastolic pressure and volume compared to WT littermates. We found an increase in histologically diffuse cardiac fibrosis in Het compared to WT in TAC mice. This study shows that a pattern of DCM can be induced by TAC-mediated pressure overload in a TTN-truncated mouse model. This model enlarges our arsenal of cardiac disease models, adding a valuable tool to understand cardiac pathophysiological remodeling processes and to develop therapeutic approaches to combat heart failure.

Figures

Figure 1
Figure 1
Schematic of the study design.
Figure 2
Figure 2
Echocardiographic and LV pressure assessments of WT and Het mice at baseline, week 1, and week 2 following TAC. (a) There is no evidence of LV dilatation in either genotype in either the presence or absence of TAC. (b) The onset of ventricular hypertrophy appears to be more rapid in the Het group demonstrating significant increases by week 1 unlike WT mice which only manifest significant thickening by week 2. (c) The reduction in EF% induced by TAC in the Het group is significant by week 2, unlike the WT TAC mice which tended to demonstrate a fall in this measure of contractile function but did not reach significance at either time point after TAC surgery. (d) Differences in EDP between groups do not reach significance although the trend is towards increase in both TAC groups. Interestingly the EDV trend although also not significant for the Het TAC group moves to the right of the Sham Het group, a change reflective of ventricular dilatation, whereas the EDV of the WT TAC mice changes little and even moves to the left more aligned to a physiological adaptation (Ŧp < 0.05). Sample sizes are also shown.
Figure 3
Figure 3
Myocardial histology of 4 representative heart sections from wild-type and Het animals 2 weeks after TAC, stained with Masson's trichrome. One representative Sham heart per genotype is also shown. Note the increased level of fibrosis in Het hearts (p < 0.01) compared to their WT littermates. Bar = 1 mm.

References

    1. Nichols M., Townsend N., Scarborough P., Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. European Heart Journal. 2014;35(42):2950–2959. doi: 10.1093/eurheartj/ehu299.
    1. Morita H., Seidman J., Seidman C. E. Genetic causes of human heart failure. The Journal of Clinical Investigation. 2005;115(3):518–526. doi: 10.1172/jci200524351.
    1. Granzier H. L., Labeit S. The giant protein titin. A major player in myocardial mechanics, signaling, and disease. Circulation Research. 2004;94(3):284–295. doi: 10.1161/01.res.0000117769.88862.f8.
    1. Labeit S., Kolmerer B. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science. 1995;270(5234):293–296. doi: 10.1126/science.270.5234.293.
    1. Linke W. A. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovascular Research. 2008;77(4):637–648. doi: 10.1016/j.cardiores.2007.03.029.
    1. Gerull B., Gramlich M., Atherton J., et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nature Genetics. 2002;30(2):201–204. doi: 10.1038/ng815.
    1. Herman D. S., Lam L., Taylor M. R. G., et al. Truncations of titin causing dilated cardiomyopathy. The New England Journal of Medicine. 2012;366(7):619–628. doi: 10.1056/NEJMoa1110186.
    1. Roberts A. M., Ware J. S., Herman D. S., et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Science Translational Medicine. 2015;7(270) doi: 10.1126/scitranslmed.3010134.
    1. Gramlich M., Michely B., Krohne C., et al. Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. Journal of Molecular and Cellular Cardiology. 2009;47(3):352–358. doi: 10.1016/j.yjmcc.2009.04.014.
    1. Cohn J. N., Ferrari R., Sharpe N. Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Journal of the American College of Cardiology. 2000;35(3):569–582. doi: 10.1016/s0735-1097(99)00630-0.
    1. Kehat I., Molkentin J. D. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010;122(25):2727–2735. doi: 10.1161/CIRCULATIONAHA.110.942268.
    1. Yoshimura M., Yasue H., Okumura K., et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation. 1993;87(2):464–469. doi: 10.1161/01.CIR.87.2.464.
    1. Gotthardt M., Hammer R. E., Hübner N., et al. Conditional expression of mutant M-line titins results in cardiomyopathy with altered sarcomere structure. Journal of Biological Chemistry. 2003;278(8):6059–6065. doi: 10.1074/jbc.m211723200.
    1. Hoshijima M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. The American Journal of Physiology—Heart and Circulatory Physiology. 2006;290(4):H1313–H1325. doi: 10.1152/ajpheart.00816.2005.
    1. Lange S., Auerbach D., McLoughlin P., et al. Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2. Journal of Cell Science. 2002;115(24):4925–4936. doi: 10.1242/jcs.00181.
    1. Witt S. H., Granzier H., Witt C. C., Labeit S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination. Journal of Molecular Biology. 2005;350(4):713–722. doi: 10.1016/j.jmb.2005.05.021.
    1. Lamark T., Kirkin V., Dikic I., Johansen T. NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle. 2009;8(13):1986–1990. doi: 10.4161/cc.8.13.8892.
    1. Gramlich M., Pane L. S., Zhou Q. F., et al. Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. EMBO Molecular Medicine. 2015;7:562–576.
    1. Granzier H., Labeit S. Structure-function relations of the giant elastic protein titin in striated and smooth muscle cells. Muscle and Nerve. 2007;36(6):740–755. doi: 10.1002/mus.20886.
    1. Miller M. K., Granzier H., Ehler E., Gregorio C. C. The sensitive giant: the role of titin-based stretch sensing complexes in the heart. Trends in Cell Biology. 2004;14(3):119–126. doi: 10.1016/j.tcb.2004.01.003.
    1. Lange S., Xiang F., Yakovenko A., et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science. 2005;308(5728):1599–1603. doi: 10.1126/science.1110463.

Source: PubMed

3
구독하다